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nitiation of cell migration requires morphological polariza-
tion with formation of a dominant leading pseudopodium
and rear compartment. A molecular understanding of this
process has been limited, due to the inability to biochemically
separate the leading pseudopodium from the rear of the cell.
Here we examine the spatio-temporal localization and activa-
tion of cytoskeletal-associated signals in puriﬁed pseudopo-
dia directed to undergo growth or retraction. Pseudopodia
growth requires assembly of a p130Crk-associated sub-
strate (CAS)/c-CrkII (Crk) scaffold, which facilitates translo-
cation and activation of Rac1. Interestingly, Rac1 activation
I
 
then serves as a positive-feedback loop to maintain CAS/
Crk coupling and pseudopodia extension. Conversely, dis-
assembly of this molecular scaffold is critical for export
and down regulation of Rac1 activity and induction of
pseudopodia retraction. Surprisingly, the uncoupling of Crk
from CAS during pseudopodium retraction is independent
of changes in focal adhesion kinase activity and CAS tyrosine
phosphorylation. These ﬁndings establish CAS/Crk as an
essential scaffold for Rac1-mediated pseudopodia growth
and retraction, and illustrate spatio-temporal segregation of
cytoskeletal signals during cell polarization.
 
Introduction
 
Directed cell movement or chemotaxis is exhibited during
wound healing, angiogenesis, embryonic development, and
immune function (Lauffenburger and Horwitz, 1996). This
process is highly conserved, as prokaryotes and eukaryotes
from 
 
Dictyostelium discoideum
 
 to human leukocytes exhibit
the ability to sense and move in the direction of a chemoat-
tractant (Parent and Devreotes, 1999; Jin et al., 2000;
Servant et al., 2000). Recent evidence indicates that when
eukaryotic cells encounter a chemoattractant gradient they
respond by local activation and amplification of signals on
the side facing the gradient (Parent et al., 1998; Meili et al.,
1999; Jin et al., 2000; Servant et al., 2000). These signals
facilitate localized actin polymerization leading to membrane
protrusion in the direction of the gradient. The protrusion of
a dominant leading pseudopodium (or lamellipodium) marks
the first sign of morphological polarity with establishment of
an anterior and posterior compartment, and occurs indepen-
dently of cell body translocation or chemotaxis (Lauffenburger
and Horwitz, 1996; Parent and Devreotes, 1999). Once a
dominant pseudopodium is formed, cell movement com-
mences in the direction of the gradient as the cell undergoes
a cycle of membrane extension at the front and contraction
at the rear.
Recent work has shown that integrin-cytoskeletal linkages,
chemokine receptors, and actin regulatory proteins are
spatially regulated in migratory cells (Ridley et al., 1992;
Schmidt et al., 1993; Manes et al., 1999; Nobes and Hall,
1999; Eddy et al., 2000). Adhesive signals by integrins may
also spatially localize to extending pseudopodia where they
fine tune and maintain directional growth while suppressing
retraction and detachment mechanisms (Smilenov et al.,
1999; Kiosses et al., 2001; Laukaitis et al., 2001). Significant
progress has also been made in determining the intracellu-
lar organization in migratory cells of pleckstrin homology
(PH)*-domain proteins, integrins, and the small GTPase
Rac1 using GFP technology (Meili et al., 1999; Jin et al.,
2000; Servant et al., 2000; Kraynov et al., 2001; Laukaitis et
al., 2001). However, this work is typically done in individual
cells, preventing molecular and biochemical evaluation of
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chemotactic signals and their spatio-temporal association
with regulatory proteins and scaffolds. This is due to the lack
of cellular material available for analysis, as well as the inabil-
ity to specifically isolate the pseudopodium and cell body for
biochemical comparison using previous techniques. The
biochemical purification of the pseudopodium and cell body
is necessary to understand the molecular detail of entire sig-
naling networks and spatio-temporal mechanisms of regula-
tion including protein translocation, activation/phosphory-
lation, and formation of complex multiprotein scaffolds. In
this work we provide evidence for purification of pseudopo-
dia induced to undergo growth or retraction, and demon-
strate the spatial, dynamic assembly of the CAS/Crk/Rac
signaling complex that controls this process.
 
Results
 
LPA induces cell chemotaxis, but not chemokinesis
 
Directional cell migration or chemotaxis requires cells to
sense the direction and proximity of a chemoattractant. This
requires activation of localized signals and actin polymeriza-
tion on the cell membrane facing the gradient. On the other
hand, random migration or chemokinesis on the other hand
is persistent cell movement in the absence or presence of a
uniform concentration of chemokine (Lauffenburger and
Horwitz, 1996). To determine whether lysophosphatidic
acid (LPA) (Fukushima et al., 2001) and insulin induced di-
rected or random cell migration, NIH 3T3 and COS-7 cells
were examined for cell migration through 8.0-
 
 
 
m porous
membranes in the presence of either a gradient or uniform
concentration of these chemokines. Only cells exposed to an
LPA gradient were induced to migrate, indicating that LPA
is a true chemoattractant and does not facilitate random cell
migration (Fig. 1). LPA-induced chemotaxis was dose de-
pendent and reached a maximum with 100–200 ng/ml. In
contrast, insulin promoted random migration, but was a
poor chemoattractant for both cell types (Fig. 1).
 
Cells extend pseudopodia through 3.0-
 
 
 
m pores in 
response to a chemoattractant gradient, independent 
of cell body translocation
 
When cells respond to a chemoattractant gradient they ex-
tend pseudopodia in the direction of the chemokine before
cell translocation. The formation of a dominant leading
pseudopodium establishes cell polarity and the future direc-
tion of chemotaxis. These observations prompted us to
determine whether cells would polarize by extending
pseudopodia through 3.0-
 
 
 
m porous membranes toward a
chemoattractant gradient, independent of cell body translo-
cation. Indeed, cells exposed to a gradient, but not a uni-
form concentration of LPA, extend pseudopodia through
small pores specifically in the direction of the gradient (Fig.
2, a–c). As expected, cells exposed to a gradient of insulin
failed to polarize and extend pseudopodia through the pores
(unpublished data). Using a confocal microscope sequen-
tially focused at the upper and lower membrane surface, we
determined that 
 
 
 
90% of the cells polarize by extending
pseudopodia in response to an LPA gradient (unpublished
Figure 1.  Lysophosphatidic acid is a potent chemoattractant for NIH 3T3 and COS-7 cells. (a) NIH 3T3 cells were examined for cell 
migration for 3 h in 8.0- m porous Boyden chambers containing different concentrations of LPA or insulin placed in the bottom, top, or top 
and bottom compartments. The number of migratory cells per microscopic field (200 ) on the underside of the membrane was counted as 
described in Materials and methods. (b) COS-7 cells were examined for cell migration as described in panel a. Each point represents the 
mean   SEM of three triplicate migration chambers of three independent experiments. 
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data). Extension of pseudopodia through 3.0-
 
 
 
m pores was
first detected 10–15 min after exposure to the LPA gradient
and proceeded linearly for 60–90 min (Fig. 2, a and b). For-
mation of the LPA gradient under these conditions was
steep and linear for at least 3 h (Fig. 2 d). In addition, nuclei
were not detected (DAPI staining) on the lower surface of
Figure 2.  Cells extend pseudopodia through 3.0- m pores toward an LPA gradient, but not a uniform concentration of LPA. (a) NIH 3T3 cells 
were allowed to attach to fibronectin coated 3.0-  m porous membranes for 2 h. Pseudopodia extension was then examined for various times in the 
absence (NT) or presence of LPA (100 ng/ml) in the bottom, top, or top and bottom compartments. Pseudopodia protein on the underside of the 
membrane was determined as described in Materials and methods. Each point represents the mean   SEM of three triplicate membranes of three 
independent experiments. (b) COS-7 cells were examined for pseudopodia protrusion as described in panel a. (c) Confocal images of NIH 3T3 
pseudopodia protrusion on the undersurface of a 3.0- m porous membrane in response to LPA (100 ng/ml) as a gradient (LPA bottom) or uniform 
concentration (LPA top and bottom). Cells were labeled with cell tracker green and then fixed at the indicated times to visualize protruding 
pseudopodia on the undersurface of the membrane. Bar, 15  m. (d) Diffusion of 
3H-LPA (100 ng/ml) from the lower chamber to the upper chamber 
through a 3.0- m porous membrane was measured at the times indicated. Each point represents the mean counts per minute (CPM)   SEM of three 
triplicate chambers of three independent experiments. (e) COS-7 cells transfected with dominant negative Rac1 (Rac N17), Cdc42 (Cdc42N17), 
or the empty vector (mock) were examined for pseudopodia formation toward an LPA gradient for 60 min as described in (a). Each bar represents 
the mean   SEM of three triplicate membranes of three independent experiments. An aliquot of cells used for the pseudopodia assay was also 
lysed and Western blotted for exogenous Rac and Cdc42 expression. RacN17 and Cdc42N17 are myc- and HA-tagged, respectively, and 
thus show reduced mobility in SDS-PAGE relative to endogenous proteins (Wt). (f) An aliquot of cells transfected as in panel e was examined 
for cell adhesion to collagen-coated dishes for 30 min in the presence or absence (NT) of LPA (100 ng/ml) as described in Materials and 
methods. Results are reported as cells attached per microscopic field (200 ). Each bar represents the mean   SEM of five fields of three 
triplicate wells of three independent experiments. 
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the membrane, but were restricted solely to the cell body on
the upper surface, indicating that only pseudopodia pro-
trude through the pores (unpublished data). Most impor-
tantly, pseudopodia extension was prevented in cells express-
ing dominant negative mutants of the small GTPase Rac1
(RacN17) or Cdc42 (Cdc42N17) (Ridley et al., 1992) (Fig.
2, e and f). Rac and Cdc42 are well established to control
cell polarity through regulation of actin protrusive processes
at the leading front of migratory cells (Allen et al., 1998;
Nobes and Hall, 1999; Etienne-Manneville and Hall,
2001). Together, these findings indicate that cells establish
polarity by extending leading pseudopodia through 3.0-
 
 
 
m
pores toward a gradient of LPA in a Rac and Cdc42 depen-
dent manner.
 
Pseudopodia retract upon removal of a 
chemoattractant gradient
 
Given that the cells polarized toward a chemoattractant gra-
dient, removing the gradient should induce pseudopodia re-
traction and loss of cell polarity. To investigate this possibil-
Figure 3.  Pseudopodia retract upon removal of an LPA gradient. (a) Pseudopodia extension of NIH 3T3 cells through 3.0- m pores toward 
an LPA gradient was examined for the indicated times, or the LPA gradient was removed after 60 min and pseudopodia were allowed to 
retract for the indicated times (LPA Removed). Total pseudopodia protein on the underside of the membrane was determined as described 
in Materials and methods. Each point represents the mean   SEM of three triplicate membranes of three independent experiments. (b) 
Pseudopodia were allowed to extend for 60 min (time 0) toward an LPA gradient as described in panel a. The gradient was then removed 
and pseudopodia were fixed at the indicated times. Cells were labeled with cell tracker green (CTG) to visualize retracting pseudopodia 
on the undersurface of the membrane by confocal microscopy. Bar, 15  m. (c) NIH 3T3 cells labeled with CTG were allowed to extend 
pseudopodia through 3.0- m pores toward an LPA gradient for 60 min. The LPA gradient was then removed (time 0) and the pseudopodia 
allowed to retract for the indicated times. Time-lapse images of retracting pseudopodia were taken with a confocal microscope focused at 
the pore–membrane interface on the undersurface of the polycarbonate membrane. See Video 1 (available at http://www.jcb.org/cgi/content/
full/jcb.200111032/DC1) for a movie illustrating pseudopodia retraction. Bar, 15  m. (d) COS-7 cell pseudopodia extension toward an LPA 
gradient was determined in the presence or absence (NT) of function-blocking antibodies to  v 5 and  1 integrins (25  g/ml) for the 
indicated times. Percent pseudopodia growth is the amount of pseudopodia protein on the undersurface of the membrane induced by cells 
exposed to an LPA gradient relative to cells in the absence of LPA. (e) Retraction of COS-7 cell pseudopodia were determined as described 
in panel a in the presence or absence (NT) of antibodies to  v 5 and  1 integrins (25  g/ml) for the indicated times. Each point represents 
the mean   SEM of three triplicate membranes of three independent experiments. 
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ity, cells were induced to extend pseudopodia toward an
LPA gradient for 60 min. The gradient was then removed
from the lower chamber and pseudopodia retraction was
examined for various times. Loss of the LPA gradient was
sufficient to reverse the polarized phenotype and induce
pseudopodia retraction (Fig. 3, a and b). Confocal imaging
and time-lapse determination revealed that pseudopodia re-
traction began within 5 min of removing the gradient and
proceeded for 2 h (Fig. 3 c). No new pseudopodia exten-
sions were observed during this time period, and 
 
 
 
80% of
the cells displayed pseuodopodia retraction under these con-
ditions (unpublished data). As expected, restoring the LPA
gradient to these cells inhibited the retraction process and
induced pseudopodia growth (unpublished data). Therefore,
cells retract their pseudopodia protrusions and lose cell po-
larity upon removal of the chemoattractant gradient.
Recent evidence indicates that integrin adhesion receptors
play a critical role in facilitating and maintaining directional
growth of pseudopodia on extracellular matrix (ECM) pro-
teins (Bailly et al., 1998; Kiosses et al., 2001; Laukaitis et al.,
2001). To investigate whether integrins were necessary for
pseudopodia extension on a collagen substrate, COS-7 cells
were allowed to attach to collagen-coated membranes for 2 h
and then exposed to an LPA gradient in the presence of
function-blocking antibodies to 
 
 
 
1 integrins, which facili-
tates attachment of these cells to collagen (Cho and Klemke,
2000). The anti-
 
 
 
1 antibody prevented pseudopodia growth
on collagen, whereas control antibodies to the vitronectin
receptor 
 
 
 
v
 
 
 
5 present on these cells did not (Fig. 3 d). Im-
portantly, the 
 
 
 
1 blocking antibodies specifically prevented
pseudopodia extension and did not cause detachment of the
cell body from the substratum (unpublished data). The anti-
 
 
 
1 antibodies did not alter pseudopodia retraction, indicating
that formation of new adhesion contacts were not necessary
for the retraction process per se (Fig. 3 e). These findings
demonstrate that integrins are necessary for pseudopodia
growth on the ECM, and provide additional evidence that
new pseudopodia do not extend through the pores after the
gradient is removed, as this would depend on new integrin
contacts.
 
Purification of growing and retracting pseudopodia
 
The above findings indicate that pseudopodia growth and
retraction is a dynamic process involving changes in focal
adhesions and the actin cytoskeleton. To directly examine
cytoskeletal components as well as complex signaling path-
ways that control cell polarity, we sought to biochemically
separate the cell into its leading pseudopodium and cell
body for protein analysis. Our findings that cells polarize by
extending pseudopodia through 3.0-
 
 
 
m pores, only in the
direction of a chemoattractant gradient, presented us with a
unique opportunity to separate and purify these structures.
Cells were allowed to extend pseudopodia for 60 min to-
ward a chemoattractant gradient or the gradient was re-
moved and cells were allowed to retract for 30 min. At these
times, the chemoattractant gradient as well as pseudopodia
growth and retraction are linear (Fig. 2). The cell body on
the upper surface of the membrane was manually removed
and the pseudopodia on the undersurface extracted with de-
tergent. The cell body was purified in a similar manner ex-
cept that pseudopodia on the lower surface were manually
removed and the cell body on the upper surface extracted
with detergent. The total profile of proteins isolated from
the cell body and pseudopodium was normalized and then
analyzed by one-dimensional SDS-PAGE. As expected,
abundant proteins were similar in the cell body and
pseudopodium, indicating that the samples were normalized
appropriately (Fig. 4 a). However, nuclear histones were
clearly absent from the pseudopodium, providing additional
evidence for the selective purification of this structure (14–
18- and 30-kD proteins) (Fig. 4 a).
 
Analysis of cytoskeletal-associated proteins 
and tyrosine phosphorylation in growing 
and retracting pseudopodia
 
Next, we examined the expression of several cytoskeletal
proteins previously associated with pseudopodia structures
in cells. Caldesmon, dynamin II, paxillin, and filamin were
all substantially increased in the pseudopodium (Fig. 4 b)
(Ridley et al., 1992; Helfman et al., 1999; Ohta et al., 1999;
McNiven et al., 2000; Laukaitis et al., 2001). In contrast,
the actin-severing protein gelsolin was restricted to the cell
body proper and was not present in the pseudopodium,
whereas extracellular-regulated kinase (ERK)2 did not show
a spatial change in polarized cells (Azuma et al., 1998). Im-
portantly, Rho, Rac, and Cdc42 showed significantly in-
creased activity in the extending pseudopodium compared
with the cell body (Fig. 4 c). Associated with the increased
GTPase activity was increased Rho and Rac, but not Cdc42
protein levels, in the pseudopodium. On the other hand, re-
tracting pseudopodia showed decreased Rho, Rac, and
Cdc42 activity, as well as decreased Rho and Rac protein
levels. However, whereas Rho activity was clearly decreased
during retraction, a notable amount of Rho activity re-
mained in the pseudopodium under these conditions (Fig. 4
c). There was also a small increase in Rho activity in the
body of retracting cells. Rho may play an important role in
both growth and retraction processes through its ability to
regulate Rac and Cdc42 activity as well as the actin/myosin
contractile machinery (Schmitz et al., 2000). Pseudopodia
isolated after 15 and 90 min of growth or 15 and 90 min of
retraction showed identical results (unpublished data). It is
important to note that during LPA-induced pseudopodia
growth there is no change in Rho, Rac, or Cdc42 activity in
the cell body relative to the nontreated whole cell group.
Thus, it is clear that the cell body on the upper surface does
not simultaneously extend pseudopodia, as this would also
lead to increased GTPase activity in the upper compart-
ment. Together, these findings demonstrate the biochemical
purification of pseudopodia and the spatial segregation of
cytoskeletal regulatory proteins in polarized cells.
Establishment of a leading pseudopodium requires spatial
regulation of actin polymerization and formation of focal
adhesions, which is associated with tyrosine phosphorylation
of cellular proteins (Lauffenburger and Horwitz, 1996; Ap-
lin et al., 1998). Therefore, we examined the phosphoty-
rosine protein profile in the cell body and pseudopodium of
cells polarized towards a chemoattractant gradient. Phos-
phoproteins of 220, 125–130, 100, and 70 kD were present
in purified pseudopodia and either absent or dephosphory- 
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Figure 4.
 
  Biochemical characterization of cytoskeletal-regulatory proteins in growing and retracting pseudopodia. 
 
(a) NIH 3T3 cells were 
allowed to extend pseudopodia toward an LPA gradient (100 ng/ml) for 60 min (growth), or the LPA gradient was removed and pseudopodia 
allowed to retract for 30 min (retraction). Proteins (10 
 
 
 
g) isolated from the cell body on the upper membrane surface or pseudopodia 
(Pseudo) on the lower membrane surface were resolved by one-dimensional SDS-PAGE and GelCode Staining (Pierce Chemical Co.) as 
described in Materials and methods. Total cellular proteins were also isolated from cells attached to culture dishes either not treated (NT) or 
treated with a uniform concentration of LPA for 60 min (growth control). Cells were also treated with a uniform concentration of LPA for 60 
min and then washed and proteins isolated after 30 min of retraction (retraction control). Arrowheads indicate nuclear histone proteins which 
are absent in purified pseudopodia. (b) Proteins isolated as described in panel a were analyzed by Western blotting using antibodies to the 
indicated proteins. Whole cell represents total cellular protein isolated from untreated cells attached to fibronectin coated dishes for 90 min. 
(c) Proteins prepared from NIH 3T3 cells as described in panel a were examined for GTP-bound activated Rac and Cdc42 using the p21-binding 
domain of PAK, which selectively binds Rac- and Cdc42-GTP. Rho-GTP was detected using the Rhotekin Rho binding domain. GTP bound 
(active) or total protein (total) in the corresponding whole-cell lysates was detected by Western blotting as described in Materials and methods. 
Densitometry was used to determine the ratio of GTP bound Rac, Cdc42, and Rho to the total GTPase protein present in an aliquot of the 
same protein lysates used for the activity assay. Fold increase represents the change in GTPase activity in the cell body and pseudopodial 
fractions relative to basal GTPase activity present in untreated whole cells (NT). (d) NIH 3T3 cells were either held in suspension for 30 min 
(sus) or allowed to attach for 2 h to either fibronectin coated culture dishes, or the upper surface of a 3.0-
 
 
 
m porous membrane coated with 
fibronectin. Whole cells on culture dishes or pseudopodia in the growth and retraction phase were isolated as described in panel a and 
analyzed for tyrosine phosphorylation by Western blotting with anti-phosphotyrosine antibodies. Blots treated with ECL reagent were 
exposed to film for 30 and 90 s. Arrowheads indicate proteins with increased phosphotyrosine in purified pseudopodia. Asterisk shows proteins 
with increased phosphotyrosine in retracting pseudopodia. (e) Total proteins isolated as described in (d) were analyzed by Western blotting 
with phosphorylation site–specific antibodies to FAK at tyrosine’s 397 (autophosphorylation, c-src and PI3K binding sites), 576, and 577  
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lated in the cell body (Fig. 4 d). Importantly, these proteins
were dephosphorylated in suspension cells, indicating that
their phosphorylation is dependent on cell adhesion to the
ECM. In contrast, phosphoproteins of 74 and 28 kD were
present in the cell body and either absent or dephosphory-
lated in the pseudopodium. Phosphotyrosine proteins ap-
peared similar under growth and retraction conditions
except for a prominent 40-kD protein that was phosphory-
lated only in pseudopodia undergoing retraction, but not
growth, suggesting a possible role for this protein in the re-
traction process (Fig. 4 d).
Analysis of the focal adhesion–associated proteins FAK,
CAS, and PLC
 
 
 
-1 revealed that these p120–130-kD phos-
phoproteins were strongly activated/phosphorylated during
pseudopodia growth as well as retraction, although there
may be a small decrease in FAK 576 and 577 phosphoryla-
 
(catalytic activation sites). Blots were stripped and reprobed with antibodies to FAK protein to evaluate the level of FAK protein present in the 
lysates. (f) Proteins isolated as described in (a) were either analyzed by Western blotting with phosphorylation-site specific antibodies to 
tyrosine 783 of human PLC
 
 
 
-1 or immunoprecipitated with antibodies to CAS and then immunoblotted with antiphosphotyrosine antibodies. 
NT is total cellular protein isolated from untreated cells attached to fibronectin coated dishes for 120 min. Arrows indicate tyrosine phosphorylated 
proteins of 85 (p85), and 70 kD (p70) that coimmunprecipitate with CAS specifically in growing, but not retracting pseudopodia. Arrowhead 
shows a tyrosine-phosphorylated protein of 60 kD that coimmunoprecipitates with CAS in the cell body, but not pseudopodia of polarized 
cells. IgH is the immunoglobulin heavy chain.
Figure 5.  CAS/Crk coupling and Rac 
activity regulate pseudopodia growth 
and retraction. (a) NIH 3T3 cells attach 
to fibronectin coated 3.0- m porous 
membranes were allowed to extend 
pseudopodia toward a LPA gradient 
(100 ng/ml) for 60 min (growth), or the 
LPA gradient was removed and the 
pseudopodia allowed to retract for 30 
min (retraction). Proteins isolated from 
the cell body or pseudopodia under 
growth or retraction conditions were 
prepared as described in Fig. 4 a. Total 
cellular protein (NT) was also isolated 
from cells attached to culture dishes in 
the absence of LPA. CAS or Crk was 
then immunoprecipitated and Western 
blotted for associated Crk or CAS, 
respectively. Also, FAK association 
with CAS was examined in the CAS 
immunoprecipitates by Western blotting 
with FAK specific antibodies. (b) COS-7 
cells were transfected with the empty 
vector (Mock) or the vector encoding 
either CAS with its substrate domain 
truncated (CAS-SD) or Crk with a 
mutated SH2 domain (Crk-SH2). Cells 
were then examined for pseudopodia 
extension in response to a LPA gradient 
(100 ng/ml) or left untreated for 60 min. 
Pseudopodia protein was determined as 
described in Materials and methods. (c) 
COS-7 cells were transfected with the 
empty vector (Mock) or vectors encoding 
CAS and Crk. Cells were then examined 
for pseudopodia extension in response 
to a LPA gradient (100 ng/ml) or not 
treated for 60 min. Pseudopodia protein 
on the underside of the membrane was 
determined as described in Materials 
and methods. (d) COS-7 cells transfected 
as in panel c were allowed to extend 
pseudopodia toward an LPA gradient 
(100 ng/ml) for 60 min (growth), or the 
LPA gradient was removed and the 
pseudopodia allowed to retract for 30 
min (retraction). Pseudopodia protein was determined as described in Materials and methods. The bottom panel shows CAS/Crk coupling 
in purified pseudopodia undergoing growth (60 min) or retraction (60 min) from cells transfected as described in panel c. (e) Cell body and 
pseudopodia proteins prepared from cells treated as described in panel c were examined for activated Rac or total Rac protein in whole 
cell lysates as described in Fig. 4 c. 
732 The Journal of Cell Biology 
 
|
 
 
 
Volume 156, Number 4, 2002
 
tion during retraction (Fig. 4, e and f). Importantly, the rel-
ative levels of FAK, CAS, and PLC
 
 
 
-1 were similar in the
pseudopodium and cell body of polarized cells during
growth and retraction. Thus, the protein level and tyrosine
phosphorylation of these signals do not change significantly
(Fig. 4, e and f), even though pseudopodium growth/retrac-
tion involves dynamic focal contact remodelling and actin
cytoskeletal changes. These findings suggest that general de-
phosphorylation or loss of focal adhesion–associated signals
is not the primary mechanism responsible for pseudopo-
dium retraction and detachment from the substratum.
Thus, the process of pseudopodia retraction is not simply
the reverse of the signaling processes that mediate growth.
This is significantly different than cell detachment from the
ECM, which is accompanied by complete dephosphoryla-
tion and inactivation of FAK, CAS, and PLC
 
 
 
-1 (Aplin et
al., 1998).
 
Assembly and disassembly of a CAS/Crk complex 
controls Rac localization and activity, 
which is necessary for pseudopodia 
growth and retraction, respectively
 
What role then does tyrosine phosphorylation of these and
other cytoskeletal regulatory proteins play during pseudopo-
dia growth and retraction? One possibility is that these pro-
teins assemble specific signaling scaffolds consisting of
unique kinases, substrates, and effector proteins that regulate
this process. To investigate this possibility, we examined the
formation of a FAK/CAS/Crk protein complex, as the spa-
tio-temporal assembly of this scaffold and its role in mediat-
ing cell migration are poorly understood (Klemke et al.,
1998). Interestingly, Crk strongly associated with CAS in
growing but was significantly reduced in retracting pseu-
dopodia (Fig. 5 a). The interaction was specific to the
pseudopodium, as CAS isolated from the cell body of polar-
ized cells did not show Crk binding. In contrast, FAK,
which binds to the src-homology (SH)3 domain of CAS,
showed no difference in binding to CAS under these condi-
tions (Fig. 5 a). In addition, we observed several tyrosine-
phosphorylated proteins that coimmunoprecipitated with
CAS in growing, but not retracting pseudopodia (Fig. 4 f).
In contrast, a 60-kD phosphoprotein associated with CAS
only in the cell body, but not the pseudopodium. Denatur-
ation of cellular proteins before CAS immunoprecipitation
prevented the association of these proteins with CAS, indi-
cating that the interaction is specific and not related to anti-
body cross-reactivity (unpublished data). Thus, CAS/Crk
complexes assemble and disassemble in a highly spatial man-
ner during pseudopodia extension and retraction.
Cell adhesion to the ECM promotes Crk binding via its
SH2 domain to phosphotyrosine residues present in the sub-
strate domain of CAS, whereas cell detachment causes com-
plete dephosphorylation of CAS and disassembly of CAS/
Crk complexes (Vuori et al., 1996; Klemke et al., 1998).
Therefore, it is surprising that the overall level of protein
and tyrosine phosphorylation of CAS does not change dur-
ing pseudopodium retraction and detachment from the
ECM, but Crk binding does. This suggests that assembly
and disassembly of CAS/Crk in the pseudopodium is tightly
regulated through phosphorylation/dephosphorylation of a
specific subset of tyrosine residues present in CAS. Alterna-
tively, phosphorylation of the regulatory tyrosine 221 of
Crk, which prevents CAS/Crk coupling in cells, may regu-
late this process (Kain and Klemke, 2001). However, we did
not detect significant changes in tyrosine phosphorylation of
Crk during pseudopodia growth and retraction (unpub-
lished data). Therefore, tyrosine phosphorylation of the sub-
strate domain of CAS may be a critical event involved in
CAS/Crk coupling and pseudopodium formation. To di-
rectly test this possibility, we examined pseudopodia forma-
tion in cells expressing CAS with its substrate domain de-
leted (CAS-SD). CAS-SD or Crk with a mutated SH2
domain (Crk-SH2) serve as dominant negative proteins pre-
venting CAS/Crk coupling and Rac activation in motile cells
(Klemke et al., 1998). Expression of CAS-SD or Crk-SH2
prevented pseudopodia extension in response to an LPA gra-
dient (Fig. 5 b). These findings demonstrate that CAS/Crk
coupling is necessary for cell polarization and extension of a
leading pseudopodium.
To investigate whether CAS/Crk coupling could enhance
pseudopodia extension, we exogenously expressed full-
length CAS and Crk in cells. However, these cells did not
show a significant change in pseudopodia extension in re-
sponse to an LPA gradient, suggesting that these molecular
signals are not limiting to the process of gradient sensing and
chemotaxis and that an additional component(s) is required
Figure 6.  Rac activity regulates assembly of CAS/Crk complexes 
in cells. COS-7 cells were transfected with CAS and Crk along 
with either myc-tagged dominant negative (RacN17) or dominant 
positive (RacQ61L) Rac1. Cells were then lysed in detergent 
(whole cell lysate) and examined for either (a) assembly of CAS/Crk 
complexes as described in Fig. 5 a; or (b) changes in FAK and 
PLC -1 activity as described in Fig. 4, e and f. Blots were stripped 
and reprobed with antibodies to FAK and PLC -1 to confirm equal 
protein loading. 
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to mediate this process (Fig. 5 c). This is different from hap-
totaxis migration, as exogenous CAS/Crk coupling in cells is
sufficient to facilitate strong migration as well as pseudopo-
dia extension (unpublished data) toward an adhesive gradi-
ent of ECM protein in the absence of a soluble chemoattrac-
tant (Klemke et al., 1998). Surprisingly, whereas increased
CAS/Crk coupling in these cells did not impact pseudopo-
dia extension, it did prevent membrane retraction, when the
gradient was removed (Fig. 5 d). In this case, CAS/Crk com-
plexes were not disassembled, and the activation and translo-
cation of Rac into pseudopodia were persistent (Fig. 5, d
and e). These findings suggest that sustained Rac activity
sends a positive feedback signal to upstream kinases/phos-
phatases that regulate CAS/Crk coupling and pseudopo-
dium extension. To investigate this possibility, we examined
CAS/Crk coupling in cells expressing dominant negative
RacN17. Inhibition of Rac activity in cells significantly
decreased CAS/Crk coupling, which was independent of
changes in FAK and PLC
 
 
 
-1 activity (Fig. 6, a and b).
Moreover, the inhibition of CAS/Crk coupling was inde-
pendent of changes in overall CAS tyrosine phosphoryla-
tion. Expression of activated RacQ61L in cells did not alter
CAS/Crk coupling, indicating that this complex was maxi-
mally activated in these cells (Fig. 6 a). Therefore, Rac can
operate upstream to specifically regulate assembly of CAS/
Crk complexes in cells. This supports the idea that Rac acti-
vation serves as a positive feedback signal to modulate CAS/
Crk coupling in migratory cells. Together, our findings
demonstrate that assembly of a CAS/Crk complex is impor-
tant for pseudopodia extension, whereas disassembly facili-
tates retraction through deactivation of Rac and its export
from this cellular structure. A model depicting the role of
CAS/Crk coupling in regulating Rac-mediated pseudopo-
dium dynamics in chemotactic cells is shown in Fig. 7 and
discussed below.
 
Discussion
 
We provide several lines of evidence for the biochemical pu-
rification of pseudopodia. First, 
 
 
 
90% of cells polarize by
extending pseudopodia through 3.0-
 
 
 
m pores in the direc-
tion of a chemoattractant gradient, whereas cells exposed to
a uniform concentration of chemokine do not. Importantly,
pseudopodium extension was directional and proceeded in a
linear manner, independent of cell body translocation,
which allowed us to differentially isolate this structure from
the cell body. Second, cytoskeletal regulatory proteins pre-
viously associated with pseudopodia-like structures were
Figure 7.  Proposed model for the role of CAS/Crk coupling in regulation of Rac-mediated pseudopodial dynamics. (Left) Model illustrating 
the basic steps of cell polarization and chemotaxis on the ECM. (Step 1) Stationary cells are attached to the underlying ECM through integrin 
receptors (squares). Cells are then exposed to a soluble gradient of growth/factor or chemokine (Step 2). This activates cell surface chemattractant 
receptors leading to activation and amplification of Rac signaling events on the side facing the gradient. (Step 3). Rho, Cdc42, and Rac then 
regulate localized actin dynamics as well as force requirements leading to membrane protrusion in the direction of the gradient. This process 
is independent of actual cell body translocation or chemotaxis and marks the first sign of morphological polarity with establishment of a 
dominant leading pseudopodium and posterior compartment. Importantly, evidence indicates that the initial protrusion of a pseudopodium 
at the cell surface is independent of integrins and the ECM contacts. However, integrins do play a critical role in pseudopodial dynamics by 
tethering the extending membrane to the substratum, which initiates the molecular coupling of CAS and Crk. CAS/Crk coupling in turn 
mediates Rac activity leading to sustained and directional pseudopodium growth. A pseudopodium that does not attach to the ECM rapidly 
retracts back to the cell body. (Step 4) Once a dominant pseudopodium is formed, cell movement commences in the direction of the gradient 
as the cell undergoes repeated cycles of membrane protrusion, adhesion to the ECM, and CAS/Crk/Rac activation. Importantly, our findings 
suggest that sustained Rac activity then provides a positive feedback signal to maintain CAS/Crk coupling and membrane extension at the 
leading front as the cell moves on the ECM (Fig. 7, right panel; Discussion). On the other hand, loss of the chemoattractant gradient or 
inappropriate contact with the ECM terminates pseudopodium extension, turning off CAS/Crk/Rac activity and chemotaxis. Therefore, in 
this model integrin ligation events at the leading front of the extending membrane cooperate with chemoattractant receptors to fine tune 
and maintain directional growth, while suppressing retraction mechanisms through regulation of CAS/Crk and Rac. 
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present in protein extracts using this fractionation method
(Fig. 4). In contrast, nuclear histones associated with the cell
body region of polarized cells were not present in the
pseudopodial extract. Finally, and most importantly, Rac
and Cdc42 activity were increased in extending, but not re-
tracting pseudopodia. Moreover, Rac and Cdc42 activity
were necessary for this response as expression of a dominant
negative forms of these proteins in cells prevented pseudopo-
dia extension. Rac and Cdc42 are well documented to facili-
tate actin-based protrusive mechanisms leading to mem-
brane extension and polarity in migratory cells (Ridley et al.,
1992; Nobes and Hall, 1999). Together, these findings
demonstrate that cells polarize by extending pseudopodia
through 3.0-
 
 
 
m pores in the direction of a chemoattractant,
and that it is possible to purify these structures for biochem-
ical analysis.
An important aspect of this model is the ability to dif-
ferentially control pseudopodia growth and retraction.
Whereas nonpolarized cells in culture have been observed to
extend and retract exploratory pseudopodia, the addition of
a uniform concentration of chemoattractant only increases
these random events, with little or no cell polarization (i.e.,
extension of one dominant pseudopodium). In our system,
we were able to induce in a synchronous manner a leading
pseudopodium in 
 
 
 
90% of the cells. We found that remov-
ing the chemoattractant gradient also caused a synchronous
loss of cell polarity and retraction of pseudopodia in the ma-
jority of cells. This allowed us to differentially monitor bio-
chemical changes during pseudopodium growth as well as
retraction. This aspect of the model is particularly attractive
for studying components that regulate actin polymerization/
depolymerization, myosin contractility, and adhesive signals
that facilitate membrane attachment/detachment from the
ECM. In addition, we show that it is possible with this
model to quantify as well as visualize pseudopodia in living
cells using confocal microscopy and time-lapse imaging.
Therefore, analysis of signaling dynamics of growing and re-
tracting pseudopodia in live cells is also possible with this
system.
 
Spatio-temporal assembly/disassembly 
of a CAS/Crk complex
 
We demonstrate that CAS and Crk are specifically assem-
bled during pseudopodia growth and then disassembled dur-
ing retraction. Surprisingly, this occurred without apparent
change in the overall level of CAS tyrosine phosphorylation
or FAK activation, which is an upstream activator of CAS
(Vuori et al., 1996; Tachibana et al., 1997). One explana-
tion is that Crk couples only to a specific subset of phospho-
tyrosine residues present in the substrate domain of CAS,
which changes during pseudopodia growth and retraction.
CAS/Crk association is mediated through the binding of the
SH2 domain of Crk to phosphotyrosine residues present in
the substrate domain of CAS (Matsuda et al., 1993). In fact,
there are 15 tyrosine residues in this region of CAS that cor-
respond to potential SH2 binding motifs, 9 of which con-
form to the Crk SH2 recognition sequence (YD(V/T)P
(Klemke et al., 1998). Alternatively, regulation may occur
through serine phosphorylation of CAS (Ma et al., 2001) or
phosphorylation of the regulatory tyrosine 221 of Crk,
which prevents CAS/Crk coupling in cells (Kain and
Klemke, 2001). However, the latter is unlikely as we did not
detect a significant change in Crk tyrosine phosphorylation.
The upstream and downstream components that modulate
the assembly/disassembly of this molecular scaffold in the
pseudopodium are not yet clear, but likely candidates in-
clude c-src, PTP-PEST, and PTP-1B (Garton et al., 1996;
Liu et al., 1996; Vuori et al., 1996).
 
Translocation and activation of Rac in growing 
and retracting pseudopodia
 
The active translocation of Rac to the pseudopodium also
implies that there is an import/export mechanism that con-
trols Rac transport to the different poles of migratory cells. It
is unlikely that CAS and Crk are directly involved in this
process, as these proteins do not appear to translocate in and
out of growing and retracting pseudopodia. Rather, it is
more likely that assembly of CAS/Crk is important for
maintaining localized Rac activity within the pseudopo-
dium. For example, it may be that when cells encounter a
chemoattractant gradient, Rac (and associated regulatory
proteins) translocates to the side of the membrane facing the
gradient as previously described for PH domain proteins like
Akt (Servant et al., 2000) (Fig. 7). The localized Rac activity
then induces actin polymerization leading to protrusion of a
pseudopodium from the cell surface and recruitment of
high-affinity integrins to this region (Kiosses et al., 2001).
Interestingly, protrusion of the pseudopodium from the
membrane surface is independent of integrin ligation and at-
tachment to the ECM (Bailly et al., 1998). This clearly
places Rac activation and actin protrusive mechanisms as an
early response upstream of integrin ligation and CAS/Crk
assembly. However, pseudopodia attachment to the ECM is
critical to stabilize the protrusive structure, as protruding
membranes that do not contact the ECM readily retract
back to the cell body (Bailly et al., 1998). Therefore, it is
likely that during pseudopodia attachment to the substra-
tum, integrin activation and focal complex formation play a
central role in driving assembly of CAS/Crk, leading to sus-
tained Rac activation and persistent membrane protrusion.
Our findings suggest that the persistent Rac activity then
serves as a positive input to maintain a high level of CAS/
Crk coupling at the leading front (Fig. 7). In contrast, with-
drawal of the chemotactic signal terminates membrane ex-
tension and focal adhesion formation resulting in uncou-
pling of the CAS/Crk/Rac signaling module leading to
pseudopodium retraction. Interestingly, the disassembly of
this complex and membrane retraction occur independently
of changes in FAK and PLC
 
 
 
-1 activity, and CAS tyrosine
phosphorylation. This suggests that the Rac feedback path-
way specifically regulates CAS/Crk coupling and does not
generally block upstream integrin signaling processes. The
Rac feedback loop may target a phosphatase that dephos-
phorylates a specific tyrosine residue(s) in the substrate do-
main of CAS, which facilitates Crk binding. Apparently, in-
tegrin and cytoskeletal signals continue to play a prominent
role during pseudopodium retraction by assembling and reg-
ulating new protein scaffolds that mediate this process. 
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However, it is clear that pseudopodium retraction is not the
simple reversal of the adhesive-signaling processes that facili-
tate growth.
In summary, we purified pseudopodia in the process of
growth or retraction and biochemically examined the spatial
localization and activation of adhesion and cytoskeletal-asso-
ciated signals that control this process. We demonstrate that
pseudopodia extension and retraction require Rac activa-
tion/deactivation, respectively, through spatial assembly/dis-
assembly of a CAS/Crk protein scaffold. Our findings pro-
vide a biochemical understanding of how cytoskeletal and
adhesive signals control morphological changes necessary for
cell migration, and illustrate the dynamic spatio-temporal
complexity of signal regulation during cell polarization.
 
Materials and methods
 
Cell lines, reagents, and antibodies
 
The expression plasmid pUCCAGGS containing full-length as well as mu-
tant forms of the c-Crk cDNA were constructed as described previously
(Matsuda et al., 1993; Tanaka et al., 1993). The pEBG expression plasmid
containing wild-type CAS or CAS with an in-frame deletion of its substrate
domain (CAS-SD) has been described previously (Mayer et al., 1995).
Myc-tagged dominant negative Rac1 (N17), dominant positive Rac1
(Q61L), and HA-tagged dominant negative Cdc42 (Cdc42N17) in
pcDNA3 have been described previously (Klemke et al., 1998).
 
 
 
Antibodies
to Crk, CAS, and paxillin, were from Transduction Laboratories. Antibodies
to myc (9E10), ERK2, and FAK were from Santa Cruz Biotechnology. Anti-
bodies to phosphotyrosine (monoclonal antibody 4G10), Rho, Rac1,
Cdc42, and the GTPase activity kits for these proteins were from Upstate
Biotechnology. Goat anti–rabbit and anti–mouse antibodies were from
Bio-Rad Laboratories. Antibodies to gelsolin, filamin, the 
 
 
 
1 integrin sub-
unit, integrin 
 
 
 
v
 
 
 
5, caldesmon, and QCM migration kit were from Chemi-
con International. Phosphospecific antibodies to FAK tyrosine 397, 576,
577, and PLC
 
 
 
-1 tyrosine 783 were from Biosource International. Anti-
dynamin II antibodies were provided by Dr. Sandra Schmid (The Scripps
Research Institute, La Jolla, CA). LPA and anti-vinculin antibodies were
from Sigma-Aldrich. 
 
3
 
H-LPA (50 Ci/mmol) was from NEN Life Science
Products, Inc. Cell tracker green was from Molecular Probes, Inc. COS-7
cells were from American Type Culture Collection. Mouse NIH3T3 cells
were provided by Dr. Tony Hunter (The Salk Institute, La Jolla, CA).
 
Quantitative pseudopodia assay
 
Pseudopodia extension was monitored using a pseudopodia assay kit
(ECM 650; Chemicon International) or Costar chambers. Serum-starved
cells (75,000) were placed into the upper compartment of a chamber (6.5
 
 
 
m) equipped with a 3.0-
 
 
 
m porous polycarbonate membrane coated on
both sides with an optimal amount of ECM protein (5 
 
 
 
g/ml fibronectin or
collagen type I). Cells were allowed to attach and spread on the upper sur-
face of the membrane for 2 h, and then stimulated with LPA (Sigma-Aldrich),
insulin, or buffer only, which was placed in the lower chamber to establish
a gradient or placed in the upper and lower chamber to form a uniform
concentration. Cells were allowed to extend pseudopodia through the
pores toward the direction of the gradient for various times. To initiate
pseudopodia retraction, the chemoattractant was removed or an equiva-
lent amount of chemoattractant placed in the upper chamber to create a
uniform concentration. The cell body on the upper surface was manually
removed with a cotton swab and the total pseudopodia protein only on the
undersurface determined using BCA and a microprotein assay system
(Pierce Chemical Co.). It is also possible to stain pseudopodia with 1%
crystal violet in 2% ethanol and then elute the dye with 10% acetic acid,
which can be measured in an ELISA plate reader (OD 600) for comparison
to a standard curve as previously described (Klemke et al., 1998).
 
Purification of pseudopodia, western blotting, and GTPase 
activity assays
 
To specifically isolate proteins from growing pseudopodia, 1–1.5 
 
 
 
 10
 
6
 
cells were induced to form pseudopodia for various times as described
above or not treated using a pseudopodia isolation kit (ECM 660; Chemi-
con International) or chambers from Costar (24 mm 3.0-
 
 
 
m pores). Cells
were rinsed in excess cold PBS and either rapidly fixed in 100% ice-cold
 
methanol (Western blotting of whole-cell lysates) or not fixed (for GTPase
activity and immunoprecipitation assays). We found that the protein pro-
file of pseudopodia proteins from fixed and unfixed cells is identical under
these conditions as determined by silver staining and SDS-PAGE (unpub-
lished data). Cell bodies on the upper membrane surface were manually
removed with cotton swab and pseudopodia on the undersurface scrapped
into lysis buffer (100 mM Tris, pH 7.4, 5 mM EDTA, 150 mM NaCl, 1 mM
sodium orthovanadate, protease inhibitors [cocktail tablet; Boehringer
Mannheim Corp.]) containing the appropriate detergent for Western blot-
ting of whole-cell lysates (1% SDS), CAS/Crk coupling (1% Triton X-100),
or GTPase activity assays (Triton X-100 according to the manufacturer’s
recommendation; UBI). Cell bodies were purified in a similar manner ex-
cept that pseudopodia on the undersurface were removed and the cell
body on the upper surface scraped into lysis buffer and detergent. Retract-
ing pseudopodia were induced for various times by removing or placing
chemoatttractant in the upper chamber to create a uniform concentration
as described above. We typically obtain 25–30 
 
 
 
g of pseudopodia protein
from each 24-mm well stimulated with chemokine for 30–60 min. This
represents 
 
 
 
4–5% of the total cellular protein. Cell culture, transient trans-
fections and efficiency determinations, Western blotting, chemotaxis, and
adhesion assays were performed at least three times, and a representative
image is shown as previously described (Klemke et al., 1998). We rou-
tinely obtain transfection efficiencies in COS-7 and NIH 3T3 cells of 80
and 70%, respectively.
 
Time-lapse imaging of retracting pseudopodia
 
Cells were labeled with cell tracker green according to the manufacturer’s
recommendation (Molecular Probes). Pseudopodia retraction was initiated
by removing chemoattractant from the lower chamber as described above.
The upper compartment (6.5 
 
 
 
m) was then fitted to an Attofluor cell cham-
ber containing a glass coverslip (Molecular Probes) and placed into a stage
heater (20/20 Technologies) on a Zeiss Axiovert 100TV microscope. A Bio-
Rad 1024 confocal microscope was used to capture time-lapse images of
pseudopodia on the undersurface of the membrane every 60 s with a Zeiss
63
 
3
 
 Achostigmat lens and LaserSharp software (Bio-Rad Laboratories).
QuickTime and Adobe photoshop software were used to prepare time-
lapse movies and representative montage images for each time frame as-
sembled for comparison. Immunofluorescent staining and confocal imag-
ing of cells were performed as described (Cheresh et al., 1999).
 
Online supplemental material
 
Video 1 (available at http://www.jcb.org/cgi/content/full/jcb.200111032/
DC1) shows time-lapse images of pseudopodia retraction through 3.0-
 
 
 
m
pores as depicted in Fig. 3 C.
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